BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32681081)

  • 1. Preservation of microvascular barrier function requires CD31 receptor-induced metabolic reprogramming.
    Cheung KCP; Fanti S; Mauro C; Wang G; Nair AS; Fu H; Angeletti S; Spoto S; Fogolari M; Romano F; Aksentijevic D; Liu W; Li B; Cheng L; Jiang L; Vuononvirta J; Poobalasingam TR; Smith DM; Ciccozzi M; Solito E; Marelli-Berg FM
    Nat Commun; 2020 Jul; 11(1):3595. PubMed ID: 32681081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradation.
    Biswas P; Canosa S; Schoenfeld D; Schoenfeld J; Li P; Cheas LC; Zhang J; Cordova A; Sumpio B; Madri JA
    Am J Pathol; 2006 Jul; 169(1):314-24. PubMed ID: 16816383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perturbed differentiation of murine embryonic stem cells upon Pelota deletion due to dysregulated FOXO1/β-catenin signaling.
    Elkenani M; Nyamsuren G; Toischer K; Adham IM; Mohamed BA
    FEBS J; 2021 May; 288(10):3317-3329. PubMed ID: 33245852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-1BB signaling activates the t cell factor 1 effector/β-catenin pathway with delayed kinetics via ERK signaling and delayed PI3K/AKT activation to promote the proliferation of CD8+ T Cells.
    Lee DY; Choi BK; Lee DG; Kim YH; Kim CH; Lee SJ; Kwon BS
    PLoS One; 2013; 8(7):e69677. PubMed ID: 23874982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-muscle Mlck is required for β-catenin- and FoxO1-dependent downregulation of Cldn5 in IL-1β-mediated barrier dysfunction in brain endothelial cells.
    Beard RS; Haines RJ; Wu KY; Reynolds JJ; Davis SM; Elliott JE; Malinin NL; Chatterjee V; Cha BJ; Wu MH; Yuan SY
    J Cell Sci; 2014 Apr; 127(Pt 8):1840-53. PubMed ID: 24522189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycemia-induced ubiquitination and degradation of β-catenin with the loss of platelet endothelial cell adhesion molecule-1 in retinal endothelial cells.
    Eshaq RS; Harris NR
    Microcirculation; 2020 Feb; 27(2):e12596. PubMed ID: 31628816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AKT2 maintains brain endothelial claudin-5 expression and selective activation of IR/AKT2/FOXO1-signaling reverses barrier dysfunction.
    Beard RS; Hoettels BA; Meegan JE; Wertz TS; Cha BJ; Yang X; Oxford JT; Wu MH; Yuan SY
    J Cereb Blood Flow Metab; 2020 Feb; 40(2):374-391. PubMed ID: 30574832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN-mediated Akt/β-catenin/Foxo1 signaling regulates innate immune responses in mouse liver ischemia/reperfusion injury.
    Kamo N; Ke B; Busuttil RW; Kupiec-Weglinski JW
    Hepatology; 2013 Jan; 57(1):289-98. PubMed ID: 22807038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low shear stress induces endothelial cell apoptosis and monocyte adhesion by upregulating PECAM‑1 expression.
    Xie X; Wang F; Zhu L; Yang H; Pan D; Liu Y; Qu X; Gu Y; Li X; Chen S
    Mol Med Rep; 2020 Jun; 21(6):2580-2588. PubMed ID: 32323830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 2 Activates Brain Microvascular Endothelial Cells Resulting in Destabilization of Adherens Junctions.
    Wylezinski LS; Hawiger J
    J Biol Chem; 2016 Oct; 291(44):22913-22923. PubMed ID: 27601468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL-apoA-I induces the expression of angiopoietin like 4 (ANGPTL4) in endothelial cells via a PI3K/AKT/FOXO1 signaling pathway.
    Theofilatos D; Fotakis P; Valanti E; Sanoudou D; Zannis V; Kardassis D
    Metabolism; 2018 Oct; 87():36-47. PubMed ID: 29928895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Nuclear Zinc Finger Protein Zfat Maintains FoxO1 Protein Levels in Peripheral T Cells by Regulating the Activities of Autophagy and the Akt Signaling Pathway.
    Ishikura S; Iwaihara Y; Tanaka Y; Luo H; Nishi K; Doi K; Koyanagi M; Okamura T; Tsunoda T; Shirasawa S
    J Biol Chem; 2016 Jul; 291(29):15282-91. PubMed ID: 27226588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akt1 promotes stimuli-induced endothelial-barrier protection through FoxO-mediated tight-junction protein turnover.
    Gao F; Artham S; Sabbineni H; Al-Azayzih A; Peng XD; Hay N; Adams RH; Byzova TV; Somanath PR
    Cell Mol Life Sci; 2016 Oct; 73(20):3917-33. PubMed ID: 27113546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic activation of beta-catenin and T-cell-specific transcription factor signaling in vascular endothelium regulates fibronectin expression.
    Gelfand BD; Meller J; Pryor AW; Kahn M; Bortz PD; Wamhoff BR; Blackman BR
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1625-33. PubMed ID: 21527747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KY-226 Protects Blood-brain Barrier Function Through the Akt/FoxO1 Signaling Pathway in Brain Ischemia.
    Sun M; Shinoda Y; Fukunaga K
    Neuroscience; 2019 Feb; 399():89-102. PubMed ID: 30579831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primed T cell responses to chemokines are regulated by the immunoglobulin-like molecule CD31.
    Kishore M; Ma L; Cornish G; Nourshargh S; Marelli-Berg FM
    PLoS One; 2012; 7(6):e39433. PubMed ID: 22724015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain endothelial dysfunction in cerebral adrenoleukodystrophy.
    Musolino PL; Gong Y; Snyder JM; Jimenez S; Lok J; Lo EH; Moser AB; Grabowski EF; Frosch MP; Eichler FS
    Brain; 2015 Nov; 138(Pt 11):3206-20. PubMed ID: 26377633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperactive FOXO1 results in lack of tip stalk identity and deficient microvascular regeneration during kidney injury.
    Dang LTH; Aburatani T; Marsh GA; Johnson BG; Alimperti S; Yoon CJ; Huang A; Szak S; Nakagawa N; Gomez I; Ren S; Read SK; Sparages C; Aplin AC; Nicosia RF; Chen C; Ligresti G; Duffield JS
    Biomaterials; 2017 Oct; 141():314-329. PubMed ID: 28711779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming.
    Ren B; Best B; Ramakrishnan DP; Walcott BP; Storz P; Silverstein RL
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1197-208. PubMed ID: 27013613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor inhibits VEGF-forkhead-dependent gene expression in endothelial cells.
    Abid MR; Nadeau RJ; Spokes KC; Minami T; Li D; Shih SC; Aird WC
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2042-8. PubMed ID: 18787186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.